Labcyte, the developer of acoustic liquid transfer, with systems in all top 10 pharmaceutical companies, today announced the selection of Bioscreen Instruments Pvt. Ltd. as its exclusive distributor in India.
“Bioscreen is a leading distributor in India. They will be a great partner for us,” said Stephen Bates, Sr. Vice President of Sales, Marketing and Service of Labcyte Inc. “As we continue to expand throughout Asia, Bioscreen will help us further broaden our existing user base in the pharmaceutical industry and the contract research organizations (CROs) that service them, Bioscreen will provide them with industry-leading Labcyte acoustic technology for compound management, high-throughput and secondary screening. Bioscreen will give our new customers in India immediate support and interaction.
“Bioscreen will also introduce us to new users in the growing genomics market. We feel that with the Labcyte platforms, Bioscreen can meet the genomics customers’ needs for miniaturization, precision and accuracy while remaining contamination-free.”
“We are extremely pleased to be the Labcyte partner in India. It is a great recognition of our distributor capabilities across the entire country of India. Labcyte products will allow us to provide our customers with state-of-the-art platform technology so that they can excel in their efforts,” said Mr. S. Radha Krishnan, Managing Director of Bioscreen Instruments. “We see a great potential market for low-volume liquid handlers in India. We believe that the miniaturization capabilities provided by Labcyte technology will be especially useful for the growing genomics markets, especially for gene expression, SNP analysis and RNAi.”
“As the market moves to higher-density assays, the touchless liquid handling capabilities offered by the Labcyte acoustic products becomes essential,” said Dr. Nick Samaras, Labcyte Managing Director, Asia-Pacific. “In particular, our Echo® liquid handler provides superior results, reduces costs by eliminating consumables and reduces toxic wastes. Our platform technology is also being applied in other fields such as array formation, the microencapsulation of compounds, particle production, proteomics research, the transfer of ultra-viscous materials, cell-based biology and imaging mass spectrometry.”
New research explores how antimicrobial exposure affects Parkinson’s disease risk